FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

17 letters match. Newest first.

  1. Central Coast Multispecialty Medical Group, Inc.

    FDA warns Central Coast Multispecialty Medical Group over incomplete donor screening and eligibility for reproductive tissue.

    High risk
  2. Conceive Fertility Center

    FDA says Conceive Fertility Center in Dallas used incomplete donor screening and testing for reproductive cells.

    High risk
  3. Louisville Reproductive Center

    Louisville Reproductive Center failed to properly test and screen semen donors for infectious diseases, FDA found.

    High risk
  4. Green Valley Fertility Partners

    FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.

    High risk
  5. InVia Fertility Specialists, PLLC

    FDA warned InVia Fertility Specialists over reproductive tissue donor eligibility and missing infectious disease testing.

    High risk
  6. MG Infusions

    FDA warned MG Infusions it sells unlicensed fecal transplant products online without required approval.

    High risk
  7. Sperm Bank, Inc. dba Fertility Center of California

    FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.

    High risk
  8. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  9. New Mexico Lions Sight Conservation Foundation, Inc. dba New Mexico Lions Eye Bank

    FDA warns New Mexico eye bank over distributing eye tissue from two donors with sepsis.

    High risk
  10. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  11. Washington Fertility Center

    FDA warned Washington Fertility Center about incomplete donor eligibility screening and testing for oocytes, semen, and embryos.

    High risk
  12. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  13. The New Hope Center for Reproductive Medicine

    FDA warns Virginia Beach fertility center over incomplete donor screening and testing for reproductive tissue.

    High risk
  14. Mark S. Denker, M.D., PA dba Palm Beach Fertility Center

    FDA warns Boca Raton fertility center over failures to screen sperm and egg donors for infectious disease risk.

    High risk
  15. Cryos International USA LLC

    Cryos International USA released and distributed anonymous donor semen without required infectious disease testing and quarantine.

    High risk
  16. Smart Surgical, Inc dba Burst Biologics

    Burst Biologics distributed unapproved umbilical cord blood products as drugs while failing sterility and donor-screening rules.

    High risk
  17. Cooper Institute

    FDA warned Houston fertility clinic Cooper Institute that it failed to test and screen oocyte donors for infectious diseases.

    High risk